Evidence map›Paper›PMID 35542349›Full record

ArticleRSC advances2018

Chiral ruthenium(ii) complex as potent radiosensitizer of

Mingjun Bai, Zhaolin Zeng, Li Li, Qiong Wu, Yanyang Zhang, Tao Pan, Luwen Mu, Duo Zhu, Shouhai Guan, Qiang Xie and 1 more

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Mingjun BaiDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Zhaolin ZengDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Li LiSchool of Pharmacy, Guangdong Pharmaceutical University Guangzhou China 510006 wuqiongniu.1113@163.com.
Qiong WuSchool of Pharmacy, Guangdong Pharmaceutical University Guangzhou China 510006 wuqiongniu.1113@163.com.ORCID https://orcid.org/0000-0003-4684-1502
Yanyang ZhangDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Tao PanDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Luwen MuDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.ORCID https://orcid.org/0000-0003-4967-2214
Duo ZhuDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Shouhai GuanDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Qiang XieDepartment of Vascular Interventional Radiology, The Third Affiliated Hospital, Sun Yat-sen University 600 Tianhe Road Guangzhou Guangdong China 510630 xieqiangdoctorxie@126.com Guanshouhai1148598268@qq.com.
Wenjie MeiSchool of Pharmacy, Guangdong Pharmaceutical University Guangzhou China 510006 wuqiongniu.1113@163.com.ORCID https://orcid.org/0000-0003-1468-6317
Sun Yat-sen University · CNGuangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A chiral ruthenium(ii) complex, Λ-[Ru(bpy)

Identifiers

PMID35542349
PMCPMC9080800
OpenAlexW2806757422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.